Mark Ragosa - CHIEF FINANCIAL OFFICER at Kiniksa Pharmaceuticals International, plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
KNSA on Nasdaq
All Insider Reports
All Insider Reports

Mark Ragosa - trading volume in the past year for Kiniksa Pharmaceuticals International, plc

Holdings reported by Mark Ragosa for Kiniksa Pharmaceuticals International, plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Ordinary Share 12,086 $528,399 $43.72 09 Feb 2026 Direct
Performance Share Unit 4,876 $263,998 $17.88 01 May 2025 Direct Class A Ordinary Share
Performance Share Option 7,606 01 May 2025 Direct Class A Ordinary Share
Restricted Share Unit 0 02 Sep 2025 Direct Class A Ordinary Share
Share Option 0 09 Feb 2026 Direct Class A Ordinary Share

Transactions reported by Mark Ragosa for Kiniksa Pharmaceuticals International, plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.